Vimkunya Injection, Suspension
NDC Package 50632-018-02

View Billable Units, 11-Digit Conversion Format, and RxNorm mappings
Table of Contents
    1. Package Information
    2. Frequently Asked Questions

Package Information

Vimkunya (chikungunya vaccine, recombinant) injection is vIMKUNYA is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 12 years of age and older. This formulation utilizes a injection, suspension delivery system. Marketed by Bavarian Nordic A/s, this product is identified by NDC 50632-018 and is authorized under FDA application BLA125820.

Identification & Billing

NDC Package Code
50632-018-02
Package Description
1 SYRINGE, GLASS in 1 CARTON / .8 mL in 1 SYRINGE, GLASS (50632-018-04)
Product Code
50632-018
11-Digit Billing Format
50632001802
Billing Unit
ML - Billing unit of "milliliter" is used when a product is measured by its liquid volume.
RxNorm Crosswalk
  • RxCUI: 2707126 - chikungunya virus antigen, recombinant Senegal strain 37997 vaccine, recombinant 0.8 ML Prefilled Syringe
  • RxCUI: 2707126 - 0.8 ML chikungunya virus antigen, recombinant Senegal strain 37997 0.05 MG/ML Prefilled Syringe
  • RxCUI: 2707132 - Vimkunya vaccine, recombinant 0.8 ML Prefilled Syringe
  • RxCUI: 2707132 - 0.8 ML chikungunya virus antigen, recombinant Senegal strain 37997 0.05 MG/ML Prefilled Syringe [Vimkunya]

Clinical Specifications

Proprietary Name
Vimkunya
Non-Proprietary Name
Chikungunya Vaccine, Recombinant
Substance Name
Chikungunya Virus Senegal Strain 37997 Capsid Protein; Chikungunya Virus Senegal Strain 37997 Envelope Protein E1; Chikungunya Virus Senegal Strain 37997 Envelope Protein E2
Dosage Form
Injection, Suspension - A liquid preparation, suitable for injection, which consists of solid particles dispersed throughout a liquid phase in which the particles are not soluble. It can also consist of an oil phase dispersed throughout an aqueous phase, or vice-versa.
Administration Route
Intramuscular - Administration within a muscle.
Active Ingredient(s)
Usage Information
VIMKUNYA is a vaccine indicated for the prevention of disease caused by chikungunya virus (CHIKV) in individuals 12 years of age and older. This indication is approved under accelerated approval based on anti-CHIKV neutralizing antibody levels [see Clinical Studies (14)]. Continued approval for this indication may be contingent upon verification and description of clinical benefit in a confirmatory trial.

Regulatory & Marketing

Labeler Name
Bavarian Nordic A/s
Product Type
Vaccine
FDA Application #
BLA125820
Marketing Category
BLA - A product marketed under an approved Biologic License Application.
Start Marketing Date
03-01-2025
Listing Expiration
12-31-2027
Exclude Flag
N
Sample Package
No

Hierarchy Structure

Code Lineage

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the full disclaimer at the bottom of this page.

Frequently Asked Questions

What is the distribution configuration for this product package?

The code 50632-018-02 identifies a specific commercial package of 1 syringe, glass in 1 carton / .8 ml in 1 syringe, glass (50632-018-04) of Vimkunya, a vaccine label labeled by Bavarian Nordic A/s. This injection, suspension is formulated for intramuscular use and contains chikungunya virus senegal strain 37997 capsid protein; chikungunya virus senegal strain 37997 envelope protein e1; chikungunya virus senegal strain 37997 envelope protein e2 as the active substance.

Is this product currently listed with the FDA?

Yes, this product is active and verified within the NDC Directory. It was introduced to the market by Bavarian Nordic A/s on March 01, 2025. The current certification is valid through December 31, 2027.

How is this Bavarian Nordic A/s product billed for insurance claims?

For medical billing and reimbursement, this package follows the 11-digit CMS format: 50632001802. Quantities are measured in per "ml or milliliter", products billed per milliliter are usually products measured by liquid volume.. The table below illustrates the segment conversion from the 10-digit labeler code to the 11-digit provider format.

11-Digit Code Conversion

Billing payers usually require a 5-4-2 segment configuration. Below is the conversion from the 10-digit package format to the 11-digit billing format:

10-Digit Format (5-3-2)
50632-018-02
11-Digit CMS (5-4-2)
50632-0018-02

Note: The zero is added to the Product segment to maintain the 5-4-2 structure.